MedTrace Logo

Treatment of BV With Donaxyl and a Molecular Test of Cure

NCT04057482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2019-08-15

No results posted yet for this study

Summary

. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.

Conditions

  • Bacterial Vaginoses

Interventions

DRUG

D

treatment of BV with dequalinium chloride vaginal tablets

Sponsors & Collaborators

  • Skaraborg Hospital

    lead OTHER_GOV

Principal Investigators

  • P-G Larsson, PhD · överläkare

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-12-31
Completion
2018-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04057482 on ClinicalTrials.gov